GE HealthCare and RadNet are extending their partnership globally to offer AI-enhanced mammography systems.
Key Details
- 1GE HealthCare and RadNet first partnered in early 2024 to integrate RadNet’s DeepHealth AI breast cancer screening into GEHC mammography devices.
- 2The next phase will see this combined offering distributed internationally, beyond the initial U.S. launch.
- 3The collaboration will now include new AI tools for lesion localization, breast density assessment, and a safeguard review workflow to flag complex cases.
- 4GE HealthCare's platform features a cloud-based multimodality viewer and other workflow enhancements.
- 5RadNet operates over 400 outpatient imaging centers in 10 U.S. states.
Why It Matters
This expansion signifies increased access to advanced, AI-powered breast imaging services for providers worldwide, aiming to facilitate earlier cancer detection and tailored care strategies. The move underscores a growing trend of integrating sophisticated AI into mainstream radiology hardware across global markets.
Source
Radiology Business
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.
•Radiology Business
Vara's AI Gains World's First Approval for Radiologist-Free Mammogram Triage
Vara has secured the world's first regulatory approval for an AI tool that autonomously classifies certain mammograms as normal, bypassing radiologist review.